Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Alnylam Pharmaceuticals

Alnylam Pharmaceuticals

USalnylam.com

Alnylam has pioneered RNAi therapeutics, an innovative approach to gene silencing. We are driven by science and committed to developing transformational medicines for patients.

Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
0
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
0 rounds
No dated round yet.
Investors on record
1 edges
People
0 officers, 0 directors
No officer or director on record.
Timeline
0
No dated event.
Evidence
5 observations
Every observation on this company